Agency classClass IIOur severity:High FDA (Devices)·Z-2394-2019·Announced 2019-09-04

Bard GlidePath Hemodialysis Catheter Recalled for Tip Breakage

Bard Peripheral Vascular Inc is recalling 39 units of GlidePath Long-Term Hemodialysis Catheters because the molded tip may break or be damaged during placement.

The agency’s classification

FDA (Devices): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 3/5 (High).

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall is classified as FDA Class II. The hazard involves a structural defect (tip breakage) during a medical procedure, which presents a risk of harm, but the source text does not report specific injuries or hospitalizations, fitting the 'High' severity criteria for risk-of-harm products where injury has not yet been reported.

Plain-English summary

Bard Peripheral Vascular Inc is recalling 39 units of GlidePath Long-Term Hemodialysis Catheters with Preloaded stylet. The affected product is identified by REF/Product code 5397350, 14.5F, straight, 35cm length, and UDI 00801741012334. The specific lot number is REDN1398 with an expiration date of 3/31/2020.

The recall was initiated due to complaints that the molded tip of the tunneler breaks or is damaged during the catheter placement procedure. This defect poses a risk of injury or procedural failure during the medical intervention.

The affected units were distributed across numerous U.S. states, including AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VI, VT, WA, WI, WV, and WY. The products were also distributed to Australia and Canada. Healthcare facilities and patients who have received this specific lot should contact Bard Peripheral Vascular Inc for instructions on replacement or return.

The recalled product

Product: GlidePath Long-Term Hemodialysis Catheter with Preloaded stylet, REF/Product code:5397350, 14.5F, straight, 35cm length, BARD, UDI: 00801741012334
Manufacturer: Bard Peripheral Vascular Inc
Category: Medical Device — Hemodialysis Catheter
Hazard: structural-defect
injury-risk
Affected units: 39

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

Lot # REDN1398 Exp. 3/31/2020

Distribution

Distributed in 53 states:

Part of a larger recall action

This product is one of 28 recalled by Bard Peripheral Vascular Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 28 products in this recall →

Same manufacturer · Bard Peripheral Vascular Inc

See all →

High
Bard EnCor EnCompass Breast Biopsy System Software Recall
FDA (Devices) · 2026-10-07
High
Catheter cutdown trays recalled over damage to the outer tray
FDA (Devices) · 2026-02-25
High
Drainage catheter trays recalled over safety indicators showing the wrong position
FDA (Devices) · 2025-12-17
Moderate
Vein ablation generators recalled over software falsely flagging working catheters
FDA (Devices) · 2025-10-08
Critical
Rotarex Atherectomy Catheter Recalled for Helix Fracture Risk
FDA (Devices) · 2025-03-12

Same hazard · structural defect